Caterpillar cut its outlook for 2015 renewing concerns about the global economic recovery. The markets traded lower during the midday with the Dow slipping 21 points to 13,537. Nasdaq lost 7 points to 3153. On the upside
TheStreet affirmed its Buy rating on Las Vegas Sands (NYSE: LVS). Antares Pharma (Nasdaq: ATRS) reported upbeat clinical trial results for its Actual Human Use study for VIBEX Methotrexate to treat rheumatoid arthritis. DARA BioSciences (Nasdaq: DARA) signed agreements that provide the company with comprehensive commercial coverage across the national oncology market. On the downside Tesla Motors (Nasdaq: TSLA) blamed slower than expected production of its Model S sedan for cutting its revenue outlook for 2012. Lexmark International (NYSE: LXK) will replace RadioShack (NYSE: RSH) on the S&P MidCap 400. Gevo (Nasdaq: GEVO) will halt production of isobutanol from corn and will begin production of ethanol. In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 4 on the NYSE and on Nasdaq. The Russell 2000 which tracks small cap stocks lost 2 points to 848.